Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Segeral

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Med (New York, N.Y.)|August 9, 2025
Tecovirimat at a crossroads: What the PALM007 trial tells usOlivier Segeral, Yazdan Yazdanpanah, Alexandra Calmy
Revue Medicale Suisse|January 16, 2026
[HIV in 2025 : innovations, persistent vulnerabilities, and a future under strain]Olivier Nawej Tshikung, Olivier Segeral, Alexandra Calmy
Revue Medicale Suisse|April 14, 2023
[Monkeypox: a new emerging infectious threat?]Olivier Segeral, Stefano Musumeci, Laurent Kaiser, et al.
Journal of Travel Medicine|August 29, 2024
Effectively protecting health care workers as clade 1 mpox epidemic complexifies: a call for vaccine and antivirals deploymentStefano Musumeci, Frédérique Jacquerioz, Olivier Segeral, et al.
Revue Medicale Suisse|February 1, 2023
[News in HIV infection, long-acting injectable treatments]Olivier Nawej Tshikung, Olivier Segeral, Matthias Cavassini, et al.
Journal of Travel Medicine|October 30, 2023
Characteristics of possible mpox reinfection cases: literature reviewStefano Musumeci, Jérôme Laflamme, Laurent Kaiser, et al.
Revue Medicale Suisse|February 1, 2024
[HIV. Long-acting treatment : clinical experience, limits and future perspectives]Alex Kodiyan, Clarisse Grelier, Lydie Tuccio, et al.
Revue Medicale Suisse|April 10, 2025
[Vaccination against human papillomavirus infections. Indications, coverage and perspectives]Léa Vimpere, Ania Wisniak, Matteo Reymond, et al.
Asia-Pacific Journal of Public Health|February 4, 2026
Perspectives of HIV Prevention Policymakers, Health Care Workers and Community Workers Concerning PrEP Implementation in Cambodia: The ANRS Quali-PrEP StudyRothmony Eang, Olivier Segeral, Camilla Oliveri, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patientsMonidarin Chou, Julie Bertrand, Olivier Segeral, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Med (New York, N.Y.)|August 9, 2025
Tecovirimat at a crossroads: What the PALM007 trial tells usOlivier Segeral, Yazdan Yazdanpanah, Alexandra Calmy
Revue Medicale Suisse|January 16, 2026
[HIV in 2025 : innovations, persistent vulnerabilities, and a future under strain]Olivier Nawej Tshikung, Olivier Segeral, Alexandra Calmy
Revue Medicale Suisse|April 14, 2023
[Monkeypox: a new emerging infectious threat?]Olivier Segeral, Stefano Musumeci, Laurent Kaiser, et al.
Journal of Travel Medicine|August 29, 2024
Effectively protecting health care workers as clade 1 mpox epidemic complexifies: a call for vaccine and antivirals deploymentStefano Musumeci, Frédérique Jacquerioz, Olivier Segeral, et al.
Revue Medicale Suisse|February 1, 2023
[News in HIV infection, long-acting injectable treatments]Olivier Nawej Tshikung, Olivier Segeral, Matthias Cavassini, et al.
Journal of Travel Medicine|October 30, 2023
Characteristics of possible mpox reinfection cases: literature reviewStefano Musumeci, Jérôme Laflamme, Laurent Kaiser, et al.
Revue Medicale Suisse|February 1, 2024
[HIV. Long-acting treatment : clinical experience, limits and future perspectives]Alex Kodiyan, Clarisse Grelier, Lydie Tuccio, et al.
Revue Medicale Suisse|April 10, 2025
[Vaccination against human papillomavirus infections. Indications, coverage and perspectives]Léa Vimpere, Ania Wisniak, Matteo Reymond, et al.
Asia-Pacific Journal of Public Health|February 4, 2026
Perspectives of HIV Prevention Policymakers, Health Care Workers and Community Workers Concerning PrEP Implementation in Cambodia: The ANRS Quali-PrEP StudyRothmony Eang, Olivier Segeral, Camilla Oliveri, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patientsMonidarin Chou, Julie Bertrand, Olivier Segeral, et al.
Pageof 3